Central serous chorioretinopathy associated with administration of sympathomimetic agents.
To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity. Observational case series. Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties. In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication. Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.